An activated state of blood coagulation and fibrinolysis in patients with abdominal aortic aneurysm

American Journal of Surgery

Volumn 175, Issue 4, 1998, Pages 297-301

  Yamazumi, Kensuke ^a   Ojiro, Masataka ^a   Okumura, Hiroshi ^a   Aikou, Takashi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; D DIMER; FIBRIN DEGRADATION PRODUCT; PLASMIN; THROMBIN ANTITHROMBIN COMPLEX; TISSUE FACTOR PATHWAY INHIBITOR;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ANEURYSM SURGERY; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; AORTIC ANEURYSM, ABDOMINAL; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; CASE-CONTROL STUDIES; FEMALE; FIBRINOLYSIS; HUMANS; MALE; MIDDLE AGED;

EID: 0032053681     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(98)00014-2     Document Type: Article

References (29)

1. Rizzo RJ, McCarthy WJ, Dixit SN, et al. Collagen types and matrix protein content in human abdominal aortic aneurysms. J Vasc Surg. 10:1989;365-373.
2. Powell JT. Dilatation through loss of elastin. Greenhalgh RM, Mannic JA, Powell JT. The Cause and Management of Aneurysms. 1990;89-96 WB Saunders, London.
3. Tilson MD, Newman KM. Proteolytic mechanisms in the pathogenesis of aortic aneurysms. Yao JST, Pearse WH. Aneurysms. New Findings and Treatments. 1994;3-9 Appleton and Lange, Norwalk, CT.
4. Schneiderman J, Bordin GM, Engelberg I, et al. Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall. J Clin Invest. 96:1995;639-645.
5. Reilly JM, Sicard GA, Lucore CL. Abdominal expression of plasminogen activators in aortic aneurysmal and occlusive diaease. J Vasc Surg. 19:1994;865-872.
6. Thompson RW, Holmes DR, Mertens RA, et al. Production and localization of 92-kolodalton gelatinase in abdominal aortic aneurysms. J Clin Invest. 96:1995;318-326.
7. Mulcare RJ, Royster TS, Phillips LL. Intravascular coagulation in surgical procedures on the abdominal aorta. Surg Gynecol Obstet. 143:1976;730-734.
8. Fisher DF, Yawn DH, Crowford ES. Preoperative disseminated intravascular coagulation associated with aortic aneurysms. A prospective study of 76 cases. Arch Surg. 118:1983;1252-1255.
9. Hawkey CJ, Stiring Y, Chakrabarti R, et al. Haemostatic changes following surgery. Thromb Res. 32:1983;223-237.
10. Meade TW. The epidemiology of haemostatic and other variables in coronary artery disease. Verstraete M, Vermylen J, Lijnen HR, Arnout J. Thrombosis and Haemostasis. 1987;37-60 International Society on Thrombosis and Haemostasis and Leuven University Press, Leuven.
11. Ahn SS, Rutherford RB, Johnston KW, et al. Reporting standards for infrarenal endovascular abdominal aortic aneurysm repair. J Vasc Surg. 25:1997;405-410.
12. Clauss A. Gerinnungsphysiologishe Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol (Basel). 17:1957;237-246.
13. Kanda T, Kaneko K, Yamauchi Y, et al. Indium 111-labeled platelate accumulation over abdominal aortic graft with chronic disseminated intravascular coagulation - a case history. Angiology. 44:1993;420-424.
14. Busuttil RW, Abou-Zamzam AM, Machleder HI. Collagenase activity of the human aorta comparison of patients with and without abdominal aortic aneurysms . Arch Surg. 115:1980;1373-1378.
15. Dobrin PB, Baker WH, Gley WC. Elastolytic and collagenolytic studies of arteries implications for the mechanical properties of aneurysms . Arch Surg. 119:1984;405-409.
16. Jean-Claude J, Newman KM, Li H, et al. Possible key role for plasmin in the pathogenesis of abdominal aortic aneurysms. Surgery. 116:1994;472-478.
17. Satta J, Laara E, Juvonen T. Intraluminal thrombus predicts rupture of an abdominal aortic aneurysm. J Vasc Surg. 23:1996;737-739.
18. Wolf YG, Thomas WS, Brennan FG, et al. Computed tomography scanning findings associated with rapid expansion of abdominal aortic aneurysm. J Vasc Surg. 20:1994;529-538.
19. Taylor FB Jr, Charg A, Ruf W, et al. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock. 33:1991;127-134.
20. Auger MJ, Mackie MJ. Monocyte procoagulant activity in breast cancer. Thromb Res. 47:1987;77-84.
21. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA. 86:1989;2839-2843.
22. Wada H, Nakase T, Nakaya H, et al. Elevated plasma tissue factor antigen level in patients with disseminated intravascular coagulation. Am J Hematol. 45:1994;232-236.
23. Carson SD, Perry GA, Pirruccello SJ. Fibroblast tissue factor calcium and ionophore induce shape changes, release of membrane vesicles and redistribution of tissue factor antigen in addition to increased procoagulant activity . Blood. 84:1994;526-534.
24. Rapaport SI, Rao LVM. The tissue factor pathway: how it has become a "prima ballerina" Thromb Haemostas. 74:1995;7-17.
25. Novotony WF, Brown SG, Miletich JP, et al. Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples. Blood. 78:1991;387-393.
26. Hoppensteadt DA, Walenga JM, Fasanella A, et al. TFPI antigen levels in normal human volunteers after intravenous and subcutaneous administration of unfractionated heparin and low molecular weight heparin. Thromb Res. 77:1995;175-185.
27. Kobayashi M, Wada H, Wakita Y, et al. Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura. Thrombo Haemost. 73:1995;10-14.
28. Kokawa T, Enjyoji K, Kumeda K, et al. Measurement of the free form of TFPI antigen in hyperlipidemia. Arterioscler Thromb Vasc Biol. 16:1996;802-808.
29. Lupu C, Lupu F, Dennehy U, et al. Thrombin induces the redistribution and acute release of tissue factor pathway inhibitor from specific granules within human endothelial cells in culture. Arterioscler Thromb Vasc Biol. 15:1995;2055-2062.